erlotinib hydrochloride has been researched along with noscapine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (noscapine) | Trials (noscapine) | Recent Studies (post-2010) (noscapine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 510 | 16 | 191 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | noscapine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 2.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 8.1773 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.4003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baitharu, I; Behera, AK; Chopdar, KS; Dash, GC; Meher, RK; Mir, SA; Mohanta, PP; Mohapatra, PK; Nayak, B; Raval, MK | 1 |
1 other study(ies) available for erlotinib hydrochloride and noscapine
| Article | Year |
|---|---|
In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2,3-b]quinazolinones as Anti-cancer Agents Targeting EGFR-TKD.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Molecular Structure; Noscapine; Protein Kinase Inhibitors; Quinazolinones; Structure-Activity Relationship; Tyrosine | 2022 |